Hyagriv Simhan, MD, MS

Director of Clinical Innovation for the Women’s Health Service Line, Executive Vice Chair for Obstetrical Services at Magee-Women's Hospital, UPMC

Hyagriv Simhan, MD, MS is Professor of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal-Fetal Medicine, at the University of Pittsburgh School of Medicine, Executive Vice Chair for Obstetrical Services at Magee-Women’s Hospital at the University of Pittsburgh Medical Center (UPMC), and Director of Clinical Innovation for the Women’s Health Service Line. Dr. Simhan completed his undergraduate studies and medical school at Boston University. Following the completion of internship and residency in Obstetrics & Gynecology at the University of Pennsylvania, Dr. Simhan completed fellowship training in Maternal-Fetal Medicine and Reproductive Infectious Diseases and Immunology at the University of Pittsburgh. He also received a Master of Science in Clinical Research from the University of Pittsburgh. Dr. Simhan leads the Hatch team in the Women’s Health Service Line at UPMC. Hatch is designed to champion clinical innovation in technology, operations, and payment strategies to advance health across the continuum of care, including outpatient, inpatient, and in the community. Hatch aims to accelerate advances in virtual care, population health, and patient engagement by coordinating, integrating, and effectively advancing progress in these domains using the full capacity of UPMC

Speaker Sessions

25. Hypertensive to Healthy: Keeping Patients Safe with Remote Monitoring

(Innovative Data and Analytics Transformation, Population Health, Quality — Course Level: Beginning)

UPMC will share how it is using remote monitoring and telehealth, especially important during the pandemic, to improve the management of hypertensive disorder in the postpartum period. Hypertensive disorders during pregnancy complicate 10-15% of pregnancies in the U.S. Hypertension is the leading cause of postpartum hospital readmissions, and among the most important contributors to prematurity and serious maternal morbidity and mortality. They are enabling ongoing connections to the healthcare team for 42 days after hospital discharge from delivery, improving maternal outcomes.

Thank You for a Great Virtual Summit! See You Next Year for HAS 21.

Replay HAS 20 Virtual

Unsupported Browser

Unfortunately your web browser is out of date. For improved security, speed and the best experience please consider using the latest version of on the following browsers: Google Chrome, Firefox, Edge, Safari, or Opera.

This site uses cookies

We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.